UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant

Cancer treatment reviews, 2015-06, Vol.41 (6), p.503-510

2015

Volltextzugriff (PDF)

Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group

International journal of radiation oncology, biology, physics, 2015-05, Vol.92 (1), p.11-31

2015

Volltextzugriff (PDF)

Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations

Radiation oncology (London, England), 2020-11, Vol.15 (1), p.254-254, Article 254

2020

Volltextzugriff (PDF)

Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)

International journal of radiation oncology, biology, physics, 2014-07, Vol.89 (4), p.854-862

2014

Volltextzugriff (PDF)

The future of anti-CD20 monoclonal antibodies: are we making progress?

Blood, 2011-03, Vol.117 (11), p.2993-3001

2011

Volltextzugriff (PDF)

Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19), p.5458-5468

2014

Volltextzugriff (PDF)

Modern Radiation Therapy for Primary Cutaneous Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group

International journal of radiation oncology, biology, physics, 2015-05, Vol.92 (1), p.32-39

2015

Volltextzugriff (PDF)

Modern Radiation Therapy for Nodal Non-Hodgkin Lymphoma—Target Definition and Dose Guidelines From the International Lymphoma Radiation Oncology Group

International journal of radiation oncology, biology, physics, 2014-05, Vol.89 (1), p.49-58

2014

Volltextzugriff (PDF)

Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma

The New England journal of medicine, 2015-04, Vol.372 (17), p.1598-1607

2015

Volltextzugriff (PDF)

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

Journal for immunotherapy of cancer, 2020-03, Vol.8 (1), p.e000337

2020

Volltextzugriff (PDF)

Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines

International journal of radiation oncology, biology, physics, 2020-08, Vol.107 (5), p.909-933

2020

Volltextzugriff (PDF)

Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study

Journal of clinical oncology, 2012-06, Vol.30 (18), p.2190-2196

2012

Volltextzugriff (PDF)

Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies

Blood, 2011-04, Vol.117 (17), p.4519-4529

2011

Volltextzugriff (PDF)

Abstract SY31-02: The interplay of radiotherapy with the tumour microenvironment: Novel opportunities to overcome adaptive resistance

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.SY31-02-SY31-02

Illidge, Tim M.

2016

Volltextzugriff (PDF)

Progress and pitfalls with the use of image-guided personalised approaches in lymphoma

British journal of radiology, 2021-11, Vol.94 (1127), p.20210609-20210609

2021

Volltextzugriff (PDF)

Is it time to rethink checkpoint blockade therapy in non‐Hodgkin lymphoma?

British journal of haematology, 2020-10, Vol.191 (1), p.13-14

2020

Volltextzugriff (PDF)

The effect of hypoxia on PD-L1 expression in bladder cancer

BMC cancer, 2021-11, Vol.21 (1), p.1271-1271, Article 1271

2021

Volltextzugriff (PDF)

Stereotactic ablative radiotherapy and immunotherapy combinations: turning the future into systemic therapy?

British journal of radiology, 2016-10, Vol.89 (1066), p.20160472-20160472

2016

Volltextzugriff (PDF)

Antibody-induced nonapoptotic cell death in human lymphoma and leukemia cells is mediated through a novel reactive oxygen species-dependent pathway

Blood, 2012-04, Vol.119 (15), p.3523-3533

2012

Volltextzugriff (PDF)

Fusion of Metabolic Function and Morphology: Sequential [18F]Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Studies Yield New Insights Into the Natural History of Bone Metastases in Breast Cancer

Journal of clinical oncology, 2007-08, Vol.25 (23), p.3440-3447

2007

Volltextzugriff (PDF)

Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin Lymphoma

Journal of clinical oncology, 2021-11, Vol.39 (32), p.3591-3601

2021

Volltextzugriff (PDF)

How do we move towards a personalised approach in the treatment of Early Hodgkin lymphoma?

British journal of haematology, 2018-07, Vol.182 (2), p.163-164

2018

Volltextzugriff (PDF)

Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1

Oncoimmunology, 2023-12, Vol.12 (1), p.2223094-2223094

2023

Volltextzugriff (PDF)

Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single UK center

Haematologica (Roma), 2013-04, Vol.98 (4), p.611-614

2013

Volltextzugriff (PDF)

The CD40 agonist HERA-CD40L results in enhanced activation of antigen presenting cells, promoting an anti-tumor effect alone and in combination with radiotherapy

Frontiers in immunology, 2023-05, Vol.14, p.1160116-1160116

2023

Volltextzugriff (PDF)

1 – 25 von 155

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(153)
Mit Volltextzugriff
(132)

Publikationsform

Artikel
(154)
Berichte
(1)

Sprache

Englisch
(155)

Erscheinungsjahr

n.n

Thema

Humans
(89)
Life Sciences & Biomedicine
(79)
Science & Technology
(79)
Oncology
(42)
Hematology
(30)
Female
(29)
Male
(29)
Treatment Outcome
(25)
Aged
(22)
Middle Aged
(22)
Adult
(20)
Biological And Medical Sciences
(19)
Radiotherapy
(19)
Immunotherapy
(18)
Lymphoma
(18)
Medical Sciences
(18)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(17)
Combined Modality Therapy
(17)
Rituximab
(16)
Antibodies, Monoclonal - Therapeutic Use
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant

Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group

Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations

Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)

The future of anti-CD20 monoclonal antibodies: are we making progress?

Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade

Modern Radiation Therapy for Primary Cutaneous Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group

Modern Radiation Therapy for Nodal Non-Hodgkin Lymphoma—Target Definition and Dose Guidelines From the International Lymphoma Radiation Oncology Group

Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines

Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study

Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies

Abstract SY31-02: The interplay of radiotherapy with the tumour microenvironment: Novel opportunities to overcome adaptive resistance

Progress and pitfalls with the use of image-guided personalised approaches in lymphoma

Is it time to rethink checkpoint blockade therapy in non‐Hodgkin lymphoma?

The effect of hypoxia on PD-L1 expression in bladder cancer

Stereotactic ablative radiotherapy and immunotherapy combinations: turning the future into systemic therapy?

Antibody-induced nonapoptotic cell death in human lymphoma and leukemia cells is mediated through a novel reactive oxygen species-dependent pathway

Fusion of Metabolic Function and Morphology: Sequential [18F]Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Studies Yield New Insights Into the Natural History of Bone Metastases in Breast Cancer

Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin Lymphoma

How do we move towards a personalised approach in the treatment of Early Hodgkin lymphoma?

Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1

Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single UK center

The CD40 agonist HERA-CD40L results in enhanced activation of antigen presenting cells, promoting an anti-tumor effect alone and in combination with radiotherapy

Suchergebnisse filtern